Prognostic models to predict complete resolution of hypertension after adrenalectomy in primary aldosteronism: A systematic review and meta-analysis

被引:2
|
作者
Marzano, Luigi [1 ,6 ]
Kazory, Amir [2 ]
Husain-Syed, Faeq [3 ]
Ronco, Claudio [4 ,5 ]
机构
[1] San Bortolo Hosp, Internal Med Unit, Vicenza, Italy
[2] Univ Florida, Div Nephrol Hypertens & Renal Transplantat, Gainesville, FL USA
[3] Justus Liebig Univ Giessen, Univ Hosp Giessen & Marburg, Dept Internal Med 2, Klin Str, Giessen, Germany
[4] Univ Padua, Dept Med DIMED, Padua, Italy
[5] San Bortolo Hosp, Int Renal Res Inst Vicenza IRRIV, Dept Nephrol Dialysis & Transplantat, Vicenza, Italy
[6] San Bortolo Hosp, Internal Med Unit, ULSS 8 Ber, I-36100 Vicenza, Italy
关键词
adrenalectomy; adrenal vein sampling; aldosterone-producing adenoma; meta-analysis; prediction model; primary aldosteronism; systematic review; LAPAROSCOPIC ADRENALECTOMY; PRIMARY HYPERALDOSTERONISM; PREVALENCE; SCORE; OUTCOMES; SURGERY; CURE; RESISTANT; DIAGNOSIS;
D O I
10.1111/cen.14918
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Complete resolution of hypertension (CRH) after adrenalectomy for primary aldosteronism is far from a certainty. Although several prognostic models have been proposed to predict outcome after adrenalectomy, studies have not clarified which of the available models can be used reliably in clinical practice. To identify, describe and appraise all prognostic models developed to predict CRH, and meta-analyse their predictive performances. We searched MEDLINE, Embase and Web of Science for development and validation studies of prognostic models. After selection, we extracted descriptive statistics and aggregated area under the receiver operator curve (AUC) using meta-analysis. From 25 eligible studies, we identified 12 prognostic models used for predicting CRH after total adrenalectomy in primary aldosteronism. We report the results for 3 models that had available data from at least 3 external validation studies: the primary aldosteronism surgical outcome (PASO) score (AUC: 0.81; 95% confidence interval [CI]: 0.74-0.86; 95% predictive interval [PI]: 0.04-1.00), Utsumi nomogram (AUC: 0.79; 95% CI: 0.72-0.85; 95% PI: 0.03-1.00) and the aldosteronoma resolution score (ARS) model (AUC: 0.77; 95% CI: 0.74-0.80; 95% PI: 0.59-0.86 for all studies and AUC: 0.80; 95% CI: 0.75-0.85; 95% PI: 0.57-0.93 for the studies with the same adrenal vein sampling-guided adrenalectomy rate compared to the models meta-analysed). The PASO score, Utsumi nomogram and ARS model showed comparable discrimination performance to predict CRH in primary aldosteronism. Unlike the ARS model, the number of external validation studies for the PASO score and the Utsumi nomogram was relatively low to draw definite conclusions.
引用
收藏
页码:17 / 34
页数:18
相关论文
共 50 条
  • [21] Confirmatory tests for the diagnosis of primary aldosteronism: A systematic review and meta-analysis
    Wu, Sicen
    Yang, Jun
    Hu, Jinbo
    Song, Ying
    He, Wenwen
    Yang, Shumin
    Luo, Rong
    Li, Qifu
    CLINICAL ENDOCRINOLOGY, 2019, 90 (05) : 641 - 648
  • [22] Minimally Invasive Partial vs. Total Adrenalectomy for the Treatment of Unilateral Primary Aldosteronism: A Systematic Review and Meta-Analysis
    Flammia, Rocco Simone
    Anceschi, Umberto
    Tufano, Antonio
    Bologna, Eugenio
    Proietti, Flavia
    Bove, Alfredo Maria
    Misuraca, Leonardo
    Mastroianni, Riccardo
    Tirone, Giuseppe
    Carrara, Alessandro
    Luciani, Lorenzo
    Cai, Tommaso
    Leonardo, Costantino
    Simone, Giuseppe
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [23] The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review
    Manosroi, Worapaka
    Phudphong, Pitchaporn
    Atthakomol, Pichitchai
    Phimphilai, Mattabhorn
    BMC ENDOCRINE DISORDERS, 2022, 22 (01)
  • [24] The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review
    Worapaka Manosroi
    Pitchaporn Phudphong
    Pichitchai Atthakomol
    Mattabhorn Phimphilai
    BMC Endocrine Disorders, 22
  • [25] Complete remission of hypertension in a hemodialysis patient after adrenalectomy for primary aldosteronism and renal transplantation
    Watanabe, Daisuke
    Morimoto, Satoshi
    Takano, Noriyoshi
    Kimura, Shihori
    Seki, Yasufumi
    Bokuda, Kanako
    Sasaki-Yatabe, Midori
    Yatabe, Junichi
    Onizuka, Hiromi
    Yamamoto, Tomoko
    Ando, Takashi
    Ichihara, Atsuhiro
    CEN CASE REPORTS, 2018, 7 (01): : 77 - 82
  • [26] Complete remission of hypertension in a hemodialysis patient after adrenalectomy for primary aldosteronism and renal transplantation
    Daisuke Watanabe
    Satoshi Morimoto
    Noriyoshi Takano
    Shihori Kimura
    Yasufumi Seki
    Kanako Bokuda
    Midori Sasaki-Yatabe
    Junichi Yatabe
    Hiromi Onizuka
    Tomoko Yamamoto
    Takashi Ando
    Atsuhiro Ichihara
    CEN Case Reports, 2018, 7 (1) : 77 - 82
  • [27] Regression of left ventricular hypertrophy in primary aldosteronism after adrenalectomy: a meta-analysis of echocardiographic studies
    Cuspidi, Cesare
    Tadic, Marijana
    Sala, Carla
    Quarti-Trevano, Fosca
    Gherbesi, Elisa
    Mancia, Giuseppe
    Grassi, Guido
    JOURNAL OF HYPERTENSION, 2021, 39 (04) : 775 - 783
  • [28] Prognosis of adrenalectomy guided by computed tomography versus adrenal vein sampling in patients with primary aldosteronism: A systematic review and meta-analysis
    Yan, Yi
    Sun, Hui-Wen
    Qi, Yue
    JOURNAL OF CLINICAL HYPERTENSION, 2022, 24 (02): : 106 - 115
  • [29] Long-Term Mortality for Patients of Primary Aldosteronism Compared With Essential Hypertension: A Systematic Review and Meta-Analysis
    Meng, Zhe
    Dai, Zhe
    Huang, Kai
    Xu, Chang
    Zhang, Yin-Gao
    Zheng, Hang
    Liu, Tong-Zu
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [30] Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis
    Monticone, Silvia
    D'Ascenzo, Fabrizio
    Moretti, Claudio
    Williams, Tracy Ann
    Veglio, Franco
    Gaita, Fiorenzo
    Mulatero, Paolo
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (01): : 41 - 50